⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.

Enalapril

انالاپریل

⚠ Unverified

❤️ Cardiovascular SystemACE inhibitor

🤰 Pregnancy:Dangerous / avoid 👶 Children:Use with caution 🇮🇷 Registered in Iran ⛔ 3 contraindications 🇺🇸 FDA approved generic (ANDA) ANDA075483 ATC C09AA02

Market / country: 🇺🇸 USA

Vasotec (US)

🧮 Dose calculator

Disease / regimen

Hypertension · Regimen source: FDA Enalapril · Dosage and Administration, Hypertension

• Usual range 10–40 mg/day in one or two doses. If a diuretic cannot be stopped: start 2.5 mg under supervision. CrCl ≤30: start 2.5 mg. FDA Enalapril · Dosage and Administration, Hypertension FDA Enalapril · Dosage and Administration, Renal Impairment

Formulation

Age *

Weight (kg) (optional)

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

⛔ History of angioedema (ACE inhibitor, hereditary or idiopathic); with sacubitril (36 h gap); aliskiren in diabetes; hypersensitivity. FDA Enalapril · Contraindications
⛔ Not recommended in neonates (no data). FDA Enalapril · Dosage and Administration, Pediatric Hypertensive Patients
⚠️ Boxed warning: fetal toxicity — stop as soon as pregnancy is detected. FDA Enalapril · Boxed Warning

Renal adjustment

• eGFR < 30: Not recommended in children with GFR <30 mL/min/1.73 m². FDA Enalapril · Dosage and Administration, Pediatric Hypertensive Patients

Formulations

2.5 mg tablet (scored) — tablet 🇺🇸 USA FDA Enalapril · How Supplied
5 mg tablet (scored) — tablet 🇺🇸 USA FDA Enalapril · How Supplied
10 mg tablet — tablet 🇺🇸 USA FDA Enalapril · How Supplied
20 mg tablet — tablet 🇺🇸 USA FDA Enalapril · How Supplied

👥 Special populations

🤰 PregnancyDangerous / avoid
Label: can cause fetal harm. Dangerous in pregnancy. FDA Enalapril · Boxed Warning
“WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.”
🤱 BreastfeedingNo data
The source for this drug has no section for this group.
👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Enalapril · Pediatric Use
“Neonates with a History of In Utero Exposure to Enalapril Maleate If oliguria or hypotension occurs, direct attention toward support of blood pressure and renal perfusion.”
👴 Older adultsNo data
The source for this drug has no section for this group.
⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.

🔗 Reference links

FDA (approval record)ANDA075483
DailyMed (FDA label)FDA Enalapril
MedlinePlus (NIH)Enalapril
WHO ATC/DDDC09AA02
Darooyab (Iran)Enalapril

🇮🇷 Registered in Iran Darooyab · G-1658/Enalapril

Dosage forms with Iranian generic codes, per Darooyab.

10666 · ENALAPRIL MALEATE 10MG TAB · قرص انالاپریل مالئات ۱۰ میلی‌گرم
13199 · ENALAPRIL MALEATE 2.5MG TAB · قرص انالاپریل مالئات ۲٫۵ میلی‌گرم
00482 · ENALAPRIL MALEATE 20MG TAB · قرص انالاپریل مالئات ۲۰ میلی‌گرم
00483 · ENALAPRIL MALEATE 5MG TAB · قرص انالاپریل مالئات ۵ میلی‌گرم

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

FDA label (DailyMed)✅ Present
FDA Enalapril · How Supplied FDA Enalapril · Dosage and Administration, Hypertension FDA Enalapril · Dosage and Administration, Renal Impairment FDA Enalapril · Dosage and Administration, Pediatric Hypertensive Patients FDA Enalapril · Pediatric Use FDA Enalapril · Dosage and Administration, Heart Failure FDA Enalapril · Dosage and Administration, Heart Failure and Renal Impairment FDA Enalapril · Contraindications FDA Enalapril · Boxed Warning FDA Enalapril · SPL approval / marketing category
UK SmPC (eMC / MHRA)❌ Not present
Published guideline❌ Not present
Licensed reference (medical school)❌ Not present
Iranian leaflet (IFDA)❌ Not present
Pharmacy website (secondary, unreliable)✅ Present
Darooyab · G-1658/Enalapril
Clinical review⚠ Unverified